MicroPort Endovascular MedTech Ltd - Asset Resilience Ratio
MicroPort Endovascular MedTech Ltd (688016) has an Asset Resilience Ratio of 2.16% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read MicroPort Endovascular MedTech Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2025–2025)
This chart shows how MicroPort Endovascular MedTech Ltd's Asset Resilience Ratio has changed over time. See 688016 total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down MicroPort Endovascular MedTech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688016 company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥100.37 Million | 2.16% |
| Total Liquid Assets | CN¥100.37 Million | 2.16% |
Asset Resilience Insights
- Limited Liquidity: MicroPort Endovascular MedTech Ltd maintains only 2.16% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
MicroPort Endovascular MedTech Ltd Industry Peers by Asset Resilience Ratio
Compare MicroPort Endovascular MedTech Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 36.63% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 9.52% |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562 |
Medical Devices | 14.72% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.47% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
Annual Asset Resilience Ratio for MicroPort Endovascular MedTech Ltd (2025–2025)
The table below shows the annual Asset Resilience Ratio data for MicroPort Endovascular MedTech Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.16% | CN¥100.37 Million ≈ $14.69 Million |
CN¥4.64 Billion ≈ $679.15 Million |
-- |
About MicroPort Endovascular MedTech Ltd
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company offers branched aortic, thoracic, and bifurcated stent graft system; abdominal aortic stent graft and delivery system; and other stent graft system in surgical operation; as well as accessorie… Read more